Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

KINEVAC Drug Profile

« Back to Dashboard

Which patents cover Kinevac, and what substitute generic drugs are available?

Kinevac is a drug marketed by Bracco and is included in one NDA. There is one patent protecting this drug.

This drug has ten patent family members in eight countries.

The generic ingredient in KINEVAC is sincalide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sincalide profile page.

Summary for Tradename: KINEVAC

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list17
Patent Applications: see list281
Drug Prices:see details
DailyMed Link:KINEVAC at DailyMed

Pharmacology for Tradename: KINEVAC

Ingredient-typeCholecystokinin
Drug ClassCholecystokinin Analog
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
KINEVAC
sincalide
INJECTABLE;INJECTION017697-001Approved Prior to Jan 1, 1982RXYesYes6,803,046► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: KINEVAC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco
KINEVAC
sincalide
INJECTABLE;INJECTION017697-001Approved Prior to Jan 1, 19823,839,315► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: KINEVAC

Country Document Number Estimated Expiration
European Patent Office1631305► Subscribe
China100374154► Subscribe
Germany60336509► Subscribe
World Intellectual Property Organization (WIPO)2005027954► Subscribe
China1756557► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc